Read + Share
Amedeo Smart
Independent Medical Education
Nagourney RA, Evans S, Tran PH, Nagourney AJ, et al. Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin. Eur J Surg Oncol 2020 Sep 19. pii: S0748-7983(20)30789.PMID: 33004272
Email
LinkedIn
Facebook
Twitter
Privacy Policy